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Impedimetric Detection and Electromediated Apoptosis of
Vascular Smooth Muscle Using Microfabricated Biosensors
for Diagnosis and Therapeutic Intervention in
Cardiovascular Diseases
Anubhav Bussooa, Daniel Hoare, Mahmut T. Kirimi, Srinjoy Mitra, Nosrat Mirzai,
Steve L. Neale, and John R. Mercer*
Cardiovascular diseases remain a significant global burden with 1-in-3 of all
deaths attributable to the consequences of the disease. The main cause is
blocked arteries which often remain undetected. Implantable medical devices
(IMDs) such as stents and grafts are often used to reopen vessels but over
time these too will re-block. A vascular biosensor is developed that can report
on cellularity and is amenable to being mounted on a stent or graft for remote
reporting. Moreover, the device is designed to also receive currents that can
induce a controlled form of cell death, apoptosis. A combined diagnostic and
therapeutic biosensor would be transformational for the treatment of vascular
diseases such as atherosclerosis and central line access. In this work, a cell
sensing and cell apoptosing system based on the same interdigitated
electrodes (IDEs) is developed. It is shown that the device is scalable and that
by miniaturizing the IDEs, the detection sensitivity is increased. Apoptosis of
vascular smooth muscle cells is monitored using continuous impedance
measurements at a frequency of 10 kHz and rates of cell death are tracked
using fluorescent dyes and live cell imaging.
1. Introduction
Cardiovascular disease (CVD) has the highest mortality rate in
the world, with 1 in 3 deaths attributable to the disease.[1] CVD is
an umbrella terms that covers a range of pathologies including
hypertension, myocardial infarction, cardiac arrest and stroke.
Blocked arteries are one of the main precursors for these events.
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The underlying pathophysiology of arte-
rial disease is caused by vascular smooth
muscle cells remodeling and blocking the
vessel in response to known risk fac-
tors such as smoking, excess alcohol, a
sedentary lifestyle and a high fat diet.
The resulting fibro-fatty plaque is termed
atherosclerosis.[2] In the heart, symptoms
often include chest pain such as angina pec-
toris caused by restriction or occlusion of
blood flow within the coronary arteries of
the heart. The narrowing of the artery lim-
its the blood flow and oxygen delivery to the
heart is diminished.[3] There are two ma-
jor ways of intervening on the vessel steno-
sis: costly coronary artery bypass grafting
(CABG)[4,5] and the widespread deployment
of intravascular stents termed percutaneous
coronary intervention (PCI) or angioplasty.
1.1. The Problem of In-Stent Restenosis
PCI involves balloon angioplasty to reopen by stenting of the cul-
prit vessel but initiates a range of acute reactions including de-
nuding of the inner endothelial layer and tearing of the medial
muscular layer, which eventually leads to neointimal regrowth
and re-blocking of the artery as part of the healing response to
injury.[6] Activation of smooth muscle cell (SMC) proliferation
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Figure 1. Concept diagram of sensor integrated onto an implantable med-
ical device. The smart sensor is deployed on a synthetic graft inside the
distal vein or artery (circled) to bypass a failed segment of vessel. The
Smart impedance device is connected to a wireless telemetry unit that
reports cellularity, pressure, and flow to a treating clinician through an
iOS/Android interface (Top image courtesy of the U.S. National Library of
Medicine (D002405); reproduced with permission).
and migration, leads to intimal wall thickening often with pro-
gression to restenosis.[7] Further work has shown that restenosis
has become a common and sometimes fatal consequence when-
ever stents or grafts are placed in the human body. Drug elut-
ing stents (DES) have significantly reduced, but not eliminated,
neointimal proliferation and restenosis for coronary artery stents,
through the suppression of SMCs proliferation and migration.
Yet their major shortcomings of silent late in-stent occlusion and
thrombosis remains.[6] With over 2 million PCI’s performed in
the USA and Europe alone there is still a clear unmet clinical
need to detect these events. Increasingly, synthetic grafts are be-
ing used to bypass disease segments of vessels. Wherever a syn-
thetic and native vessel join, a similar wound response occurs
that can silently re-block the vessel (Figure 1).
Anti-proliferative drugs such as Rapamycin (Sirolimus) are fre-
quently coated on stents and can be classified as either cytostatic
or cytotoxic drugs. These inert drug eluting stents (DES) have
been very successful but also have limitations. The polymer used
to load the drugs is associated with local inflammatory reactions
and will non-specifically elute off the stent making them an ef-
fective solution. In up to 10% of cases restenosis will still form
and be completely undetected. An alternative approach would be
to use an on-stent biosensor for detection of proliferation of cells
and detection of clot, then use local delivery of electroporation to
induce a controlled form of cell death termed apoptosis to reopen
the vessel.
1.2. Electromediated Cells Sensing and Cell Death
The pioneering work of Nobel Laurate Ivar Giaever and Charles
Keese established impedimetric cell sensing (Giaever and Keese,
1993). Ample evidence suggests that changes in electrical
impedance can be used to detect increased cellularity as the cells
act as insulators to the flow of electrical current. Mamouni and
Yang (2011)[8] carried cell sensing experiments using IDEs. The
IDE consisted of 50 pairs of fingers, with 15 µm finger width and
15 µm finger separation. In the absence of cells, and with culture
medium only, the impedance of the system comes from two com-
ponents, which are the resistance of the solution and the double
layer capacitance of the electrodes. In the presence of cells on the
electrode surface, the equivalent circuit contains the impedance
contributions from the cells in addition to the resistance of the
solution and double layer capacitance. Equally, electroporation,
which is a method of increasing the permeability of the cell
plasma membrane by passing an electric field across it, is not
new and often used in the lab but when miniaturized becomes
an appropriate method for mediating a controlled form of cell
death[9] for the next generation of implantable medical devices
(IMDs). Indeed Giaever went on to establish Applied Biosystems
to commercialize the electric cell–substrate impedance sensing
system (ECIS) (ECIS is a trademark of Applied BioPhysics Inc.).
Electroporation can be achieved in a transient state, where re-
versible hydrophilic pores are created in the cell membrane due
to changes in the phospholipids in the lipid bilayer[10] or in per-
manent state through the formation of nanopores which remain
open.[11] This allows for the insertion of fluorophores, drugs,
DNA, RNA, tracers, antibodies, ions, or other molecules to the
cell. Although this is performed in controlled conditions, some
nanopores in the membrane do not always seal after the electrical
field has been removed and cell death occurs.
Natural cell death has been identified to involve several
pathways and has a number of characteristics. In its simplest
form it can be categorised into two broad types, necrosis and
apoptosis.[12] Apoptosis the controlled and regulated cell death,
with characteristic identifiers of cell membrane blebbing, phos-
phatidylserine flipping, cell and nucleus shrinking, decreased
mitochondria permeability, release of cytochrome c and fragmen-
tation of DNA.[13,14] In contrast necrosis is an uncontrolled pro-
cess that displays no distinctive features of apoptosis nor phago-
cytosis and lysosomal digestion[15] and would be predicted to be
dangerously thrombogenic.
Piñero et al. (1997)[16] carried out an electroporation experi-
ment using HL60 human promyeloid leukemia cells to deter-
mine whether cell death was induced by apoptosis, necrosis or
both. They used a mixture of three fluorescent dyes: propidium
iodide (PI), fluorescein diacetate (FDA) and Hoeschst 33342. Nor-
mal living cells showed green (FDA) fluorescence in the cyto-
plasm and blue (Hoeschst) fluorescence in the nucleus, as both
fluorochromes can pass through intact membranes. Cells which
died either of apoptosis or necrosis, show DNA stained with red
fluorochromes (PI). Apoptotic cells show green cytoplasm with
spotted blue-stained nuclear bodies.
For many cell membranes electropermeabilization is triggered
by a threshold potential difference of 200 mV across the mem-
brane and is reversible.[17] As such the size of a cell can be-
come important, as larger cells will experience a greater potential
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Figure 2. Multiple image alignment (MIA) micrograph of large IDE and small IDE with red and blue boxes, respectively showing effective electrode area.
difference across them within the same electrical field as a
smaller cell[18] and it has been shown that the shape of the cell
can also become important.[19] When electroporation is carried
out using short high-voltage pulses, temporary increase in mem-
brane permeability can be used to enhance the transport of cal-
cium. Calcium is found intracellularly in smooth muscle cells
at < 100 × 10−9 m while extracellular calcium concentration is
≈1.2 × 10−3 m.[20] Variations in calcium homeostasis can lead
to apoptotic cell death.[10] This is due to increased cell mem-
brane permeability from electroporation increases the intracel-
lular calcium levels, which in turn lead to effects such as cessa-
tion of ATP production, cell blebbing, destruction of cytoskeleton
and cell swelling. Electroporation combined with calcium ions
is a promising anticancer therapy which is safe. Kinio and Mills
(2017) developed a microfluidic device with interdigitated elec-
trodes (IDEs) printed on the bottom and top of a microfluidic
channel. Human blood containing MCF7 cancer cells was flowed
through the channel. The interdigitated electrodes allowed frac-
tionation of the blood cells, with cancer cells closer to the top
of channel and blood cells closer to the floor of the channel. The
electric field closer to the top of the channel was strong enough to
cause irreversible electroporation and cell death. Recently, Li et al.
(2017)[21] studied electroporation of single cells using AC volt-
ages. They fabricated a microfluidic device with co-planar gold
electrodes with a separation of 10 µm. This gap allowed trap-
ping of a single Jurkat cell when a suspension of these cells was
streamed through the microfluidic channel. Membrane poration
was assessed using propidium iodide (PI) and cell viability was
assessed using Calcein AM. Using frequencies of 100 kHz and
10 MHz cell electroporation was identified at 0.6 V at 100 kHz
and 2.3 V at 10 MHz. A decrease in cell viability at 1.0 V for
100 kHz and 2.7 V for 10 MHz resulted in cell death at increased
voltages to 1.3 V for 100 kHz and at 4.2 V for 10 MHz.
Stolwijk, Michaelis, and Wegener (2012)[22] provide prece-
dence for this approach by studying the effects of applying an
invasive sinusoidal voltage pulse of 5 V and 40 kHz which was
applied for 30 s to normal rat kidney (NRK) cells using ECIS
electrodes. The cells were stained using a live–dead stain (calcein
acetoxymethyl (CAM) and ethidium homodimer (ETHD)). The
control well showed only green fluorescence (CAM) indicat-
ing that all the cells were healthy. The treatment well showed
an area of red fluorescence (ETHD) surrounded by an area of
green fluorescence, indicating that cells directly on the electrodes
were dead, while cells around the electrode were unaffected.
Their work shows that application of the pulse to the treatment
well caused a drop in normalized impedance at 400, 4000, and
40000 Hz.
Herein, we report the use of a similar microfluidic device using
interdigitated electrodes to monitor health of a primary smooth
muscle cell monolayer and to induce apoptosis of these cells us-
ing low pulse doses of alternating currents (AC). In the future we
propose in our recent reviews how these could be integrated into
existing implantable vascular devices.[23,24]
2. Experimental Section
Interdigitated electrodes (IDEs) were fabricated at the James Watt
Nanofabrication Centre of University of Glasgow using standard
microfabrication techniques (Figure 2). The photolithographic
mask used had two different sizes of IDE. The large IDE (4 mm2)
consisted of two sets of 20 fingers (length 800 µm, width 100
µm, and 100 µm separation between each finger). The small IDE
(0.5 mm2) consisted of two sets of 20 fingers (length 200 µm,
width 25 µm, and 25 µm separation between each finger). The
electrodes were patterned on a microscope slide (Sigma Aldrich,
UK) with a 10 nm titanium adhesion layer and 100 nm gold layer.
The photolithographic mask used had two different sizes of IDE
(Figure 2). A plastic chamber from a commercially available slide
chamber (Sigma Aldrich, UK) was mounted onto the patterned
glass slide using UV curable glue (Loctite, Germany). Electrical
wires were soldered to the contact pads of the small IDE.
2.1. Experimental Setup
The experimental setup consisted of a Live cell microscope
(Olympus IX71, Japan) with a temperature and CO2 controlled
enclosure (Solent Scientific, UK), an LCR meter (Hioki IM 3536,
Japan), a function generator (AimTTi – TG5011A, UK) and a PC
for interfacing with the microscope and the LCR meter. The IDEs
were connected to the LCR meter for impedance measurements
and to the function generator for applying controlled voltages for
electroporation.
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Figure 3. Live cell microscope with a temperature and CO2 controlled enclosure, an LCR meter, a function generator and a PC for interfacing with the
microscope and the LCR meter.
2.2. Primary Cell Seeding for Impedance Measurements
The fabricated device was sterilized by misting with 70% ethanol
and washing with deionized water. The baseline impedances
were first measured with culture medium only. An LCR meter
(Hioki IM3536) with a fixed current, varying voltage system was
used for measuring impedance with a constant current (CC) set-
ting of 10 µA. The impedances were measured at 10, 20, 30, 40,
and 50 kHz using an LCR meter for the large IDE and small IDE.
A frequency range of 10–40 kHz was recommended by Wang
et al. (2008)[25] for maximum sensitivity when monitoring cells
using IDE. An adherent primary vascular cell type, mouse aor-
tic smooth muscle cells (MASMCs), previously characterized,[26]
were used for all experiments. The cells were cultured in phe-
nol red free DMEM media supplemented with 10% fetal bovine
serum (FBS) in cell culture flasks. Once sub-confluent, the cells
were trypsinized and 200 000 MASMCs were then seeded into
the fabricated device, and the cell suspension was pipetted a few
times to ensure a homogeneous population was plated. MASMCs
were spherical when in suspension and spindle-shaped, once ad-
hered to the culture substrate. The cells were allowed to settle
down for 18 h inside an incubator (37 °C and 5% CO2) to ensure
that they adhered to the electrodes. Experimental impedances
were then recorded. The increases in impedance were calculated
at each frequency for the large and small IDEs.
2.3. Impedance Measurements, Time-Lapse Live Cell Imaging,
and Induction of Cell Death
Primary MASMCs were seeded into sterilized fabricated devices
(200 000 cells per mL) and grown in phenol red free DMEM
media. The devices were transferred to the microscope stage
with warmed (37 °C) and CO2 buffered enclosure and the large
IDE was connected to the LCR meter. Bright field imaging
and impedance measurements (at 10 kHz) were simultaneously
started and acquired at 15 min intervals. At the 20 h time point,
the LCR meter was disconnected from the electrodes, and the
function generator (AimTTi – TG5011A) was connected so as
to apply a sine voltage of 2 Vpeak-to-peak 40 kHz for 2 min, the
minimum duration required to observe a drop in impedance
(Figure 3). To clarify the impedance readings were indepen-
dent of the applied voltage from the function generator. Equally
changes in impedance after voltages were applied were directly
due to changes in the cellularity across the sensor surface. The
function generator was then disconnected and the LCR meter re-
connected so as to continue impedance measurements up to the
45 h timepoint and comparisons made between the small IDE
and large IDE. To provide a positive control for comparing the ef-
fects of electromediated cell death, the chemotherapeutic drug
etoposide and a mechanical scratch were used. Etoposide is a
chemotherapy drug used to treat cancer. It prevents cell prolif-
eration by inhibiting a class of DNA repair enzymes called Topoi-
somerase II.[27] Its use in the study was purely to act as a drug
based positive control to induce the controlled form of cell death
apoptosis. Equally the mechanical scratch assay was a physical
insult to the cell monolayer that would induce both uncontrolled
necrotic and apoptotic death.
2.4. Fluorescent Visualizing Apoptotic Cell Death
200 000 MASMCs were seeded (0 h timepoint of experiment) into
a fabricated device. 2 mL of Phenol-red-free DMEM was added.
The cells were allowed to settle and adhere to the bottom of the
device for 23 h inside the microscope enclosure, with impedance
measurement acquired at 10 min intervals. At 23 h, the cells were
stained using the Apoptosis/Necrosis Assay Kit (ab176749 – Ab-
cam, UK). The kit was a mixture of three dyes, CytoCalcein Vio-
let 450, Apopxin Green Indicator and 7-AAD for detecting live,
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apoptotic and necrotic cells respectively. The staining solution
was prepared by pipetting 5 µL of each of the three dyes into
500 µL of Phenol-red-free serum-free DMEM. The cell mono-
layer was carefully washed twice using Phenol-red-free serum-
free DMEM. Then the staining solution was pipetted onto the
monolayer and the dyes were allowed to incubate for 1 h. Post-
staining the staining solution was pipetted out of the cham-
ber and the monolayer was washed twice using Phenol-red-free
DMEM. Then 2 mL of fresh Phenol-red-free DMEM was pipetted
into the chamber which was transferred to the microscope stage.
2.5. Poststaining Monitoring and Application of Voltage
Microscopic images were acquired under bright field (BF) and
in the DAPI, FITC, and Texas Red fluorescent channels. This
was started at the same time as impedance measurements, and
both were acquired at 10 min intervals. The cells were monitored
from 24 h (immediately after staining) to 32 h to ensure that the
staining was not affecting cell viability. At 32 h, the chamber was
disconnected from the LCR meter and connected to a function
generator. A sine voltage of 2 V peak-to-peak 40 kHz was applied
for 2 min, the minimum duration required to observe a drop in
impedance. The chamber was then reconnected to the LCR meter
and impedance measurements resumed. The impedance and mi-
croscopic images were acquired up to the 49 h timepoint. Time-
lapse imaging and impedance measurements were stopped, and
the cell chamber was transferred to a cell culture hood again. The
staining was carried out again, in exactly the same way as before.
After the 1 h staining step, the cell chamber was transferred to the
live cell microscope again, and final BF and fluorescent images
of the cells were acquired.
3. Data Collection and Statistical Analysis
Impedance data were collected using a Hioki LCR meter IM3536
with technical replicates made using intermittent measure-
ments, as the meter probes could be disconnected and connected
to different set of electrodes between measurements. For con-
tinuous measurements the probes remained connected to only
one electrode at a time. All data presented are representative of
replicate data samples with as mean ± standard deviation (SD).
P values were calculated using student’s paired t-tests (two-tailed
distribution) when comparing two groups, one way analysis of
variance (ANOVA) was used to determine significant difference
between two or more independent groups, with a Tukey post-test
for large sample sizes. Statistical significance was displayed as P
< 0.05 (one star), P < 0.01 (two stars), or P < 0.001 (three stars).
All analysis was performed and plotted on Graph Pad Prism (v 5).
4. Results
The results from Figure 4 and Table 1 show that the mean in-
crease in impedance was higher with the small IDE as compared
to the large IDE at 10, 20, 30, 40, and 50 kHz. Optimum sens-
ing frequency range was previously determined from 10–50 kHz
(Figure S1, Supporting Information). Two-way ANOVA showed
Figure 4. Mean increases in impedance at different frequencies due to
200 000 MASMCs detected by large IDE and small IDE. Two-way ANOVA
showed that there was a statistically significant (p < 0.001) difference in
the mean increase in impedance across all the frequencies (10–50 kHz)
n = 3.
Table 1. Comparison of increases in impedance at the different frequencies
for large.
Frequency
[kHz]
[A] Impedance increase
[Ω] with large IDE
[B] Impedance increase
[Ω] with small IDE
Ratio B
A
10 26 116 4.46
20 21 90 4.29
30 19 79 4.16
40 17 73 4.29
50 15 68 4.53
Mean 4.35
the mean increases with small IDE and large IDE were signif-
icantly different (p < 0.001) at all the frequencies. The highest
increase in impedance was detected at 10 kHz for both the small
IDE and large IDE. The small IDE had an effective electrode area
16 times smaller than the effective electrode area of the large IDE.
The ratio of the mean increase with small IDE over large IDE had
a mean value of 4.35. Importantly this suggests the relationship
between mean increase in impedance detected due to MASMCs
is inversely proportional to the electrode area.
Figure 5 shows that both the large IDE and small IDE are able
to track gradual adherence of MASMCs to the electrodes sensor.
The large IDE detected an increase of ≈15 Ω when the cells had
settled down while the small IDE detected a maximum increase
of ≈150 Ω. After the application of the voltage, the impedance
dramatically dropped by 15 Ω for the large IDE and by 160 Ω for
the small IDE. In both cases, the impedance dropped approxi-
mately back to the baseline impedance at 0 h. Following this drop,
the impedance did not go back up to the pre-voltage impedance,
implying that the voltage causes a permanent effect on the cells.
However, any physical effect across the on the cells were not im-
mediately observable using bright-field microscopy (BFM). More-
over, the effects seemed to be restricted to the regions in-between
the electrode fingers rather than on the fingers. The cells around
the IDE appeared mostly unaffected by the application of the volt-
age. This implied that a very specific and localized effect can be
applied to a cell monolayer.
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Figure 5. A,B) Detection of cell adherence over time and induction of cell death by comparison of impedance measurements of large IDE (A) and small
IDE (B) performed over 45 h with a pulse voltage for 2 min applied at 20 h to induce electroporation.
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Figure 6. Impedance measurement for the whole experiment showing impedance immediately postseeding, during cell adherence, poststaining, and
postvoltage.
Figure 6 shows the impedance readings for the whole dura-
tion of the experiment (49 h). The baseline impedance at 0 h was
260 Ω. The impedance reached a maximum of 320 Ω at 10 h and
gradually decreased to 310 Ω at 22 h. This could be attributable
to a depletion of the amount of nutrients in the media, causing
the cells to detach slightly from the electrodes and establishes
the current maximum duration for these types of experiments. At
22 h, the impedance measurements were stopped and the stain-
ing step was carried out. The impedance measurements were
resumed at 24 h and acquired at 10 min intervals. The staining
solution causes the cells to detach slightly from the electrodes,
causing the impedance to drop to 250 Ω. The cells were allowed
to reattach to the electrodes until 32 h, where an impedance of
273 Ω was reached. The voltage was applied at that point, caus-
ing an immediate drop in impedance to 215 Ω. The impedance
then stayed relatively constant from this point to 49 h.
To assess the effects across the monolayer more precisely we
used fluorescent live cell imaging. To mimic the effects of me-
chanical damage that might be expected during stent deployment
to the vasculature a scratch assay was compared to a drug induced
form of cell death and used as a positive control for the subse-
quent experiments. Figure 7 shows the mean percentages of live,
apoptotic and necrotic cells for the negative control, voltage treat-
ment, scratch positive control and etoposide (a topoisomerase in-
hibitor of DNA repair) as a positive control. The negative control,
voltage treatment and scratch positive control were carried out
as part of the same experiment, while the etoposide positive con-
trol was carried out as part of a separate experiment. The live cell
percentage was based on the bright field and blue fluorescence
while the apoptotic and necrotic cell percentages were based on
the green fluorescence and red fluorescence, respectively.
The percentages were compared using one-way ANOVA with
Tukey’s multiple comparison posthoc test. For the negative con-
trol, the percentage of apoptotic cells at the endpoint was statis-
tically different (p < 0.05) from the baseline, implying that there
was an important increase in apoptosis from 8% to 18%. Com-
paring the pre-voltage treatment at baseline to the etoposide drug
positive control post-treatment highlighted a statistically differ-
ence in the percentages of live and apoptotic cells by the endpoint
(p < 0.001 and p < 0.001, respectively). This implies that the in-
duction of apoptosis using 2 V sine wave for 2 min had similar
effects to 50 × 10−6 m etoposide at 24 h. The percentage of apop-
tosis induced by the voltage was higher (46% vs 36%) compared
to etoposide. Hence, a short pulse of voltage can induce a higher
percentage apoptosis in a MASMC monolayer compared to a pro-
longed exposure to etoposide.
5. Conclusions
Intravascular biosensors have the potential to transform cardio-
vascular healthcare. A number of groups are actively researching
cell sensing technologies but few, if any, are including therapeu-
tic induction of cell death.[28–30] Here we have demonstrated that
we were able to develop a cell sensing and cell apoptosing sys-
tem based on the same interdigitated electrodes. Moreover, our
sensor is entirely scalable to virtually any size. Miniaturizing the
effective electrode area of the interdigitated electrode by a factor
of 16 (linear factor of 4) increased the sensitivity of the cell de-
tection approximately by a factor of 4.35 over the 10–50 kHz fre-
quency range. These results are in line with findings by Zhang
et al. (2017),[31] who obtained an increases in sensitivity by fac-
tors of 1.7 and 1.5 (at different cell densities), when miniaturizing
their electrodes by a linear factor of 1.5. All measurements in this
study were carried out at 8 kHz, which was the optimum sensing
frequency for their electrode design. We compared the increases
in impedance at several frequencies. Results from Figure 4 show
that the maximum impedance increases were obtained at 10
kHz for both small IDE and large IDE. Thus this frequency was
chosen for continuously monitoring cell adherence, prolifera-
tion and apoptosis. Montaño-Figueroa et al. (2019)[32] also used
10 kHz to monitor apoptosis. However, in these experiments
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Figure 7. Mean percentages of live, apoptotic, and necrotic cells at the different time points for the negative control without voltage, treatment with
voltage, positive control with scratch and positive control with 50 × 10−6 m etoposide.
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apoptosis was chemically induced, while in our experiments,
apoptosis was electrically induced. By applying a sine wave of 2 V
at 40 kHz for 2 min, the same electrodes could not only be used
for cell detection but importantly also be used to induce apop-
tosis, a controlled form of smooth muscle cell death across the
sensor surface and beyond the immediate sensing area.
The voltage characteristics in our design were similar to the
ones used by Stolwijk, Michaelis, and Wegener (2012) who stud-
ied the effects of applying an invasive sinusoidal voltage pulse
of 5 V and 40 kHz for 30 s to NRK cells. They observed a clear
area of cell death on the electrodes and an area of unaffected cells
around the electrodes. They also observed a drop in impedance
after application of the invasive voltage. However, they measured
the impedance for only a short time period of 0.5 min after voltage
application, and it is not clear whether the impedance changes
further beyond that point.
In our study, the impedance was measured for ≈25 h after volt-
age application. During that period, the impedance decreased for
the large IDE and increased for the small IDE (without reaching
the pre-voltage-application impedance).
The ECIS system provides prior art in cell detection that in-
volves the use of electric fields between electrodes to monitor be-
havior of cells (Ablin and Jiang, 2012). A small alternating cur-
rent of ≈1 µA is applied through the electrodes, resulting in a
small voltage drop of a few millivolts across the cells. From the
voltage drop and applied electric current, the impedance can be
calculated. Their system is based on the use of specialized culture
plates for in vitro evaluation only and is in no way amenable to in-
tegration onto implantable medical devices (IMDs). However, the
frequency at which the impedance is measured determines the
pathway of the electric current, thus allowing different properties
such as cell capacitance, barrier function and electrode coverage
to be monitored.
Indeed Wang et al. (2008)[25] studied the effects of varying these
parameters of interdigitated electrode on cell detection sensitiv-
ity, and concluded that electrodes were most sensitive to cells
in the 10–40 kHz range. In contrast to cell sensing Montaño-
Figueroa et al. (2019)[32] used impedance-base sensors at a sin-
gle frequency of 10 kHz to monitor the effects of chemically in-
duced apoptosis on pre-osteoblast cells but not electroinduced
cell death. Zhang et al. (2017)[31] studied the effects of changing
the electrode dimensions on the impedance increase detected but
again there is no previous art of the same sensor being used for
both cell sensing and cell death that is both scalable and ready
for integration into implantable medical devices. In separate ex-
periments, they seeded bovine aortic endothelial cells at densi-
ties of 10 000 and 20 000 cells per cm2 on working electrodes
with radii 150 and 100 µm. When comparing the same cell den-
sity, their smaller electrode provided larger impedance increases.
This showed that smaller electrode could detect finer changes in
cell density in keeping with our findings. The linear size ratio of
the large electrode to the small electrode size was 1.5. The ratio
of impedance increase of small electrode to large electrode was
1.7 at 10 000 cells per cm2 and 1.5 at 20 000 cells per cm2. These
findings point towards an inverse relation between electrode size
and increase in impedance detected that make the design of our
electrodes particularly suitable to miniature implantable medical
devices.
Indeed, the recovery profiles for the large and small IDEs in
our work are different because of the size and sensitivities of
the electrodes. The electroporation and subsequent apoptosis are
initially localized to the regions within the electrode area, that
is on and between the electrode fingers, but the “bystander ef-
fect” can extend the region of effect. Fluorescent live cell imag-
ing has allowed us to confirm this and that the cell death in-
duced by the sensor voltage was significantly attributable to
apoptosis.
With apoptosis being a much more controlled form of cell
death, where the apoptotic bodies are cleared by phagocytes, it
offers the hope of a useful system that could be integrated with
existing implantable medical devices. Indeed, we have developed
a miniaturized and implantable telemetry reporter to integrate
with our sensor that can be tested using stentable arteries ex
vivo.[33] For example, if the cell death and remote cell monitoring
using impedance measurements were developed in combination
with a vascular device, then a self-reporting diagnostic and ther-
apeutic cell sensor could be achieved. Diagnosing and assessing
cellularity using implantable medical devices is important area
of clinical research. Many human pathologies are attributable to
inappropriate growth of cells, such as cancers and many vas-
cular pathologies. Future work will now investigate the poten-
tial of integrating our design and developing clinically relevant
devices.
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